These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
129 related items for PubMed ID: 1454216
21. Changes in turnover of cerebral monoamines following inhibition of enkephalin metabolism by thiorphan and bestatin. Llorens-Cortes C, Schwartz JC. Eur J Pharmacol; 1984 Sep 17; 104(3-4):369-74. PubMed ID: 6594244 [Abstract] [Full Text] [Related]
22. Differential catabolic fate of neuromedin N and neurotensin in the canine intestinal mucosa. Barelli H, Mao YK, Vincent B, Daniel EE, Vincent JP, Checler F. Peptides; 1993 Sep 17; 14(3):457-63. PubMed ID: 8332546 [Abstract] [Full Text] [Related]
23. Effect of inhibitors of enkephalin degradation in the isolated guinea-pig ileum. van Amsterdam JG, van Buuren KJ, Krielaart MJ, Zuiderveld OP, Tijms RP. Life Sci; 1988 Sep 17; 43(19):1529-36. PubMed ID: 3193845 [Abstract] [Full Text] [Related]
24. Involvement of endopeptidase 24.15 in the inactivation of bradykinin by rat brain slices. McDermott JR, Gibson AM, Turner JD. Biochem Biophys Res Commun; 1987 Jul 15; 146(1):154-8. PubMed ID: 2886123 [Abstract] [Full Text] [Related]
25. Analgesic effects of kelatorphan, a new highly potent inhibitor of multiple enkephalin degrading enzymes. Fournie-Zaluski MC, Chaillet P, Bouboutou R, Coulaud A, Cherot P, Waksman G, Costentin J, Roques BP. Eur J Pharmacol; 1984 Jul 20; 102(3-4):525-8. PubMed ID: 6386492 [Abstract] [Full Text] [Related]
26. [Inhibition of the evoked liberation of (Met5)enkephalin from slices of globus pallidus in the presence of thiorphan and bestatin]. Giros B, de la Baume S, Gros C, Schwartz JC. C R Seances Acad Sci III; 1983 Jul 20; 297(13):609-12. PubMed ID: 6424884 [Abstract] [Full Text] [Related]
27. Enkephalin-processing oligopeptidases in cobra venom: inhibition by thiorphan and bestatin reveals co-operative actions. Anderson L, Bussler B, Martins H, Dufton M. Toxicon; 1998 May 20; 36(5):719-28. PubMed ID: 9655632 [Abstract] [Full Text] [Related]
28. Enantiomers of thiorphan and acetorphan: correlation between enkephalinase inhibition, protection of endogenous enkephalins and behavioral effects. Giros B, Gros C, Schwartz JC, Danvy D, Plaquevent JC, Duhamel L, Duhamel P, Vlaiculescu A, Costentin J, Lecomte JM. J Pharmacol Exp Ther; 1987 Nov 20; 243(2):666-73. PubMed ID: 3479550 [Abstract] [Full Text] [Related]
29. New hydroxamate inhibitors of neurotensin-degrading enzymes. Synthesis and enzyme active-site recognition. Bourdel E, Doulut S, Jarretou G, Labbe-Jullie C, Fehrentz JA, Doumbia O, Kitabgi P, Martinez J. Int J Pept Protein Res; 1996 Aug 20; 48(2):148-55. PubMed ID: 8872532 [Abstract] [Full Text] [Related]
30. Neuromedin N: high affinity interaction with brain neurotensin receptors and rapid inactivation by brain synaptic peptidases. Checler F, Vincent JP, Kitabgi P. Eur J Pharmacol; 1986 Jul 31; 126(3):239-44. PubMed ID: 3019713 [Abstract] [Full Text] [Related]
31. Centrally administered [D-Trp11]neurotensin, as well as neurotensin protected from inactivation by thiorphan, modifies locomotion in rats in a biphasic manner. Nouel D, Dubuc I, Kitabgi P, Costentin J. Peptides; 1990 Jul 31; 11(3):551-5. PubMed ID: 2381875 [Abstract] [Full Text] [Related]
32. A C-terminal cyclic 8-13 neurotensin fragment analog appears less exposed to neprilysin when it crosses the blood-brain barrier than the cerebrospinal fluid-brain barrier in mice. Van Kemmel FM, Dubuc I, Bourdel E, Fehrentz JA, Martinez J, Costentin J. Neurosci Lett; 1996 Oct 11; 217(1):58-60. PubMed ID: 8905739 [Abstract] [Full Text] [Related]
33. Inhibition of serotonin release by bombesin-like peptides in rat hypothalamus in vitro. Saporito MS, Warwick RO. Life Sci; 1989 Oct 11; 45(1):15-23. PubMed ID: 2545989 [Abstract] [Full Text] [Related]
34. Peptidases involved in the catabolism of neurotensin: inhibitor studies using superfused rat hypothalamic slices. McDermott JR, Virmani MA, Turner JD, Kidd AM. Peptides; 1986 Oct 11; 7(2):225-30. PubMed ID: 3526299 [Abstract] [Full Text] [Related]
35. Characterization of aminopeptidases responsible for inactivating endogenous (Met5)enkephalin in brain slices using peptidase inhibitors and anti-aminopeptidase M antibodies. Giros B, Gros C, Solhonne B, Schwartz JC. Mol Pharmacol; 1986 Mar 11; 29(3):281-7. PubMed ID: 2869404 [Abstract] [Full Text] [Related]
36. New bidentates as full inhibitors of enkephalin-degrading enzymes: synthesis and analgesic properties. Fournié-Zaluski MC, Coulaud A, Bouboutou R, Chaillet P, Devin J, Waksman G, Costentin J, Roques BP. J Med Chem; 1985 Sep 11; 28(9):1158-69. PubMed ID: 3897541 [Abstract] [Full Text] [Related]
37. Effect of inhibition of neuropeptidases on the pain threshold of mice and rats. Carenzi A, Frigeni V, Reggiani A, Della Bella D. Neuropharmacology; 1983 Nov 11; 22(11):1315-9. PubMed ID: 6363960 [Abstract] [Full Text] [Related]
38. Hypothermic effect of neuromedin N in mice and its potentiation by peptidase inhibitors. Dubuc I, Nouel D, Coquerel A, Menard JF, Kitabgi P, Costentin J. Eur J Pharmacol; 1988 Jun 22; 151(1):117-21. PubMed ID: 3416919 [Abstract] [Full Text] [Related]
39. Effect of a novel selective and potent phosphinic peptide inhibitor of endopeptidase 3.4.24.16 on neurotensin-induced analgesia and neuronal inactivation. Vincent B, Jiracek J, Noble F, Loog M, Roques B, Dive V, Vincent JP, Checler F. Br J Pharmacol; 1997 Jun 22; 121(4):705-10. PubMed ID: 9208137 [Abstract] [Full Text] [Related]
40. Protection by serine peptidase inhibitors of endogenous cholecystokinin released from brain slices. Rose C, Camus A, Schwartz JC. Neuroscience; 1989 Jun 22; 29(3):583-94. PubMed ID: 2739903 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]